Chongqing Bo Teng Pharmaceutical Technology Co., Ltd. 2026 Interim Performance Forecast

Porton Pharma Solutions Ltd.·July 14, 2026·2 pages

✨ AI Summary

Chongqing Bo Teng Pharmaceutical Technology Co., Ltd. forecasts a significant increase in revenue for the first half of 2026, driven by market development and new orders. However, net profit is expected to show a loss due to asset impairment provisions related to a terminated project. Excluding this, underlying profit is projected to grow substantially.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 300363

Stock Abbreviation: Bo Teng Shares

Announcement No.: 2026-043

Chongqing Bo Teng Pharmaceutical Technology Co., Ltd.

2026 Interim Performance Forecast

The Company and the entire Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or significant omissions.

I. Performance Forecast for the Current Period

(I) Performance Forecast Period

January 1, 2026 to June 30, 2026.

(II) Performance Forecast:

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.